Immutable evidence record · ticker

Regeneron Pharmaceuticals, Inc. (REGN34)

Published as observed on 16 August 2026 at 02:45 BST.

Regeneron Pharmaceuticals, Inc. has a balanced company news read. Its latest completed weekly trend is negative.

As of
16 Aug 2026, 02:45
Scope
company and instrument
Evidence
9 items
Independent sources
3
Country
Brazil
Sector
Healthcare
Previous read
47.000
Change

Verification

Evidence links

This is dated market research. Coverage may be delayed, incomplete or unavailable.

Cite this record:
Sharemaestro, Regeneron Pharmaceuticals, Inc. (REGN34), 2026-08-16, https://sharemaestro.com/evidence/84c55cd7-afe7-4c2a-a8d8-7d446db72456/
Record checksum 78ce16754f98b9f590a6b445d48f81a330ed30e87d65c21c8efcfd2c364fe6c4

Evidence context